Malta

Malta

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.61 (0.50 - 0.72) 2019 Modelled IHME
0.61 (0.50 - 0.72) 2018 Modelled IHME
0.61 (0.49 - 0.74) 2017 Modelled IHME
0.62 (0.50 - 0.74) 2016 Modelled IHME
0.64 (0.51 - 0.77) 2015 Modelled IHME
0.65 (0.52 - 0.78) 2014 Modelled IHME
0.66 (0.54 - 0.78) 2013 Modelled IHME
0.67 (0.55 - 0.79) 2012 Modelled IHME
0.68 (0.56 - 0.80) 2011 Modelled IHME
0.68 (0.56 - 0.83) 2010 Modelled IHME
0.69 (0.57 - 0.83) 2009 Modelled IHME
0.7 (0.57 - 0.83) 2008 Modelled IHME
0.7 (0.58 - 0.84) 2007 Modelled IHME
0.71 (0.58 - 0.85) 2006 Modelled IHME
0.72 (0.59 - 0.86) 2005 Modelled IHME
0.72 (0.60 - 0.87) 2004 Modelled IHME
0.73 (0.60 - 0.88) 2003 Modelled IHME
0.74 (0.61 - 0.89) 2002 Modelled IHME
0.75 (0.61 - 0.90) 2001 Modelled IHME
0.75 (0.61 - 0.92) 2000 Modelled IHME
0.76 (0.63 - 0.92) 1999 Modelled IHME
0.77 (0.63 - 0.93) 1998 Modelled IHME
0.78 (0.64 - 0.93) 1997 Modelled IHME
0.79 (0.64 - 0.94) 1996 Modelled IHME
0.79 (0.64 - 0.95) 1995 Modelled IHME
0.8 (0.65 - 0.96) 1994 Modelled IHME
0.8 (0.66 - 0.97) 1993 Modelled IHME
0.81 (0.66 - 0.97) 1992 Modelled IHME
0.81 (0.66 - 0.98) 1991 Modelled IHME
0.81 (0.66 - 0.99) 1990 Modelled IHME
1.25 (0.15 - 9.32) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.08) 2019 Modelled IHME
0.07 (0.04 - 0.09) 2018 Modelled IHME
0.07 (0.04 - 0.10) 2017 Modelled IHME
0.07 (0.04 - 0.10) 2016 Modelled IHME
0.07 (0.05 - 0.10) 2015 Modelled IHME
0.07 (0.05 - 0.10) 2014 Modelled IHME
0.08 (0.05 - 0.11) 2013 Modelled IHME
0.08 (0.06 - 0.11) 2012 Modelled IHME
0.09 (0.06 - 0.12) 2011 Modelled IHME
0.09 (0.06 - 0.13) 2010 Modelled IHME
0.09 (0.06 - 0.13) 2009 Modelled IHME
0.09 (0.06 - 0.13) 2008 Modelled IHME
0.1 (0.06 - 0.14) 2007 Modelled IHME
0.1 (0.06 - 0.14) 2006 Modelled IHME
0.1 (0.06 - 0.14) 2005 Modelled IHME
0.1 (0.06 - 0.14) 2004 Modelled IHME
0.1 (0.06 - 0.14) 2003 Modelled IHME
0.1 (0.06 - 0.14) 2002 Modelled IHME
0.1 (0.07 - 0.13) 2001 Modelled IHME
0.1 (0.07 - 0.13) 2000 Modelled IHME
0.13 (0.09 - 0.17) 1999 Modelled IHME
0.2 (0.14 - 0.26) 1998 Modelled IHME
0.29 (0.20 - 0.37) 1997 Modelled IHME
0.36 (0.24 - 0.47) 1996 Modelled IHME
0.4 (0.26 - 0.53) 1995 Modelled IHME
0.41 (0.27 - 0.54) 1994 Modelled IHME
0.41 (0.27 - 0.55) 1993 Modelled IHME
0.42 (0.28 - 0.56) 1992 Modelled IHME
0.42 (0.28 - 0.57) 1991 Modelled IHME
0.42 (0.28 - 0.57) 1990 Modelled IHME
0.39 (0.05 - 3.14) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
3,015 (2,433 - 3,671) 1990 Modelled IHME
3,032 (2,467 - 3,654) 1991 Modelled IHME
3,046 (2,484 - 3,665) 1992 Modelled IHME
3,057 (2,502 - 3,682) 1993 Modelled IHME
3,064 (2,503 - 3,684) 1994 Modelled IHME
3,069 (2,494 - 3,684) 1995 Modelled IHME
3,069 (2,494 - 3,685) 1996 Modelled IHME
3,062 (2,514 - 3,670) 1997 Modelled IHME
3,051 (2,514 - 3,668) 1998 Modelled IHME
3,038 (2,498 - 3,669) 1999 Modelled IHME
3,026 (2,468 - 3,685) 2000 Modelled IHME
3,014 (2,481 - 3,658) 2001 Modelled IHME
3,002 (2,476 - 3,614) 2002 Modelled IHME
2,990 (2,470 - 3,594) 2003 Modelled IHME
2,977 (2,456 - 3,581) 2004 Modelled IHME
2,965 (2,430 - 3,566) 2005 Modelled IHME
2,953 (2,430 - 3,533) 2006 Modelled IHME
2,941 (2,426 - 3,518) 2007 Modelled IHME
2,928 (2,414 - 3,504) 2008 Modelled IHME
2,914 (2,392 - 3,497) 2009 Modelled IHME
2,897 (2,394 - 3,501) 2010 Modelled IHME
2,879 (2,380 - 3,425) 2011 Modelled IHME
2,857 (2,350 - 3,387) 2012 Modelled IHME
2,833 (2,308 - 3,360) 2013 Modelled IHME
2,804 (2,260 - 3,345) 2014 Modelled IHME
2,771 (2,209 - 3,316) 2015 Modelled IHME
2,713 (2,163 - 3,234) 2016 Modelled IHME
2,669 (2,150 - 3,223) 2017 Modelled IHME
2,661 (2,171 - 3,174) 2018 Modelled IHME
2,664 (2,187 - 3,171) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.21 (0.91 - 1.58) 2019 Modelled IHME
1.21 (0.92 - 1.59) 2018 Modelled IHME
1.2 (0.92 - 1.58) 2017 Modelled IHME
1.18 (0.90 - 1.56) 2016 Modelled IHME
1.16 (0.88 - 1.52) 2015 Modelled IHME
1.18 (0.90 - 1.54) 2014 Modelled IHME
1.18 (0.90 - 1.54) 2013 Modelled IHME
1.18 (0.91 - 1.54) 2012 Modelled IHME
1.17 (0.90 - 1.53) 2011 Modelled IHME
1.16 (0.89 - 1.51) 2010 Modelled IHME
1.21 (0.92 - 1.55) 2009 Modelled IHME
1.32 (1 - 1.70) 2008 Modelled IHME
1.45 (1.10 - 1.86) 2007 Modelled IHME
1.55 (1.18 - 2) 2006 Modelled IHME
1.61 (1.21 - 2.08) 2005 Modelled IHME
1.61 (1.20 - 2.08) 2004 Modelled IHME
1.61 (1.21 - 2.08) 2003 Modelled IHME
1.59 (1.19 - 2.06) 2002 Modelled IHME
1.55 (1.17 - 2.01) 2001 Modelled IHME
1.53 (1.16 - 1.98) 2000 Modelled IHME
1.53 (1.16 - 1.98) 1999 Modelled IHME
1.51 (1.15 - 1.96) 1998 Modelled IHME
1.52 (1.15 - 1.97) 1997 Modelled IHME
1.49 (1.12 - 1.94) 1996 Modelled IHME
1.46 (1.10 - 1.91) 1995 Modelled IHME
1.44 (1.08 - 1.88) 1994 Modelled IHME
1.42 (1.07 - 1.85) 1993 Modelled IHME
1.4 (1.05 - 1.83) 1992 Modelled IHME
1.4 (1.04 - 1.82) 1991 Modelled IHME
1.4 (1.04 - 1.84) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
5 (4 - 7) 2019 Modelled IHME
5 (4 - 7) 2018 Modelled IHME
5 (4 - 7) 2017 Modelled IHME
5 (4 - 7) 2016 Modelled IHME
5 (4 - 7) 2015 Modelled IHME
5 (4 - 7) 2014 Modelled IHME
5 (4 - 7) 2013 Modelled IHME
5 (4 - 7) 2012 Modelled IHME
5 (4 - 7) 2011 Modelled IHME
5 (4 - 6) 2010 Modelled IHME
5 (4 - 7) 2009 Modelled IHME
6 (4 - 7) 2008 Modelled IHME
6 (5 - 8) 2007 Modelled IHME
6 (5 - 8) 2006 Modelled IHME
7 (5 - 9) 2005 Modelled IHME
7 (5 - 9) 2004 Modelled IHME
7 (5 - 8) 2003 Modelled IHME
6 (5 - 8) 2002 Modelled IHME
6 (5 - 8) 2001 Modelled IHME
6 (5 - 8) 2000 Modelled IHME
6 (5 - 8) 1999 Modelled IHME
6 (5 - 8) 1998 Modelled IHME
6 (5 - 8) 1997 Modelled IHME
6 (4 - 8) 1996 Modelled IHME
6 (4 - 7) 1995 Modelled IHME
6 (4 - 7) 1994 Modelled IHME
5 (4 - 7) 1993 Modelled IHME
5 (4 - 7) 1992 Modelled IHME
5 (4 - 7) 1991 Modelled IHME
5 (4 - 7) 1990 Modelled IHME
11 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (8 - 17) 2019 Modelled IHME
12 (8 - 17) 2018 Modelled IHME
12 (8 - 18) 2017 Modelled IHME
12 (8 - 18) 2016 Modelled IHME
12 (8 - 18) 2015 Modelled IHME
12 (8 - 18) 2014 Modelled IHME
12 (8 - 18) 2013 Modelled IHME
12 (8 - 18) 2012 Modelled IHME
12 (8 - 18) 2011 Modelled IHME
13 (9 - 18) 2010 Modelled IHME
13 (9 - 19) 2009 Modelled IHME
13 (9 - 19) 2008 Modelled IHME
13 (9 - 19) 2007 Modelled IHME
14 (9 - 20) 2006 Modelled IHME
14 (9 - 20) 2005 Modelled IHME
14 (9 - 20) 2004 Modelled IHME
14 (9 - 20) 2003 Modelled IHME
14 (9 - 20) 2002 Modelled IHME
14 (9 - 20) 2001 Modelled IHME
14 (10 - 20) 2000 Modelled IHME
14 (10 - 20) 1999 Modelled IHME
14 (10 - 20) 1998 Modelled IHME
14 (10 - 20) 1997 Modelled IHME
14 (10 - 21) 1996 Modelled IHME
14 (10 - 21) 1995 Modelled IHME
14 (10 - 21) 1994 Modelled IHME
14 (10 - 21) 1993 Modelled IHME
14 (10 - 21) 1992 Modelled IHME
14 (10 - 21) 1991 Modelled IHME
14 (10 - 21) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
88 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
95 2015 Survey/reported WHO/UNICEF
90 2014 Survey/reported WHO/UNICEF
94 2013 Survey/reported WHO/UNICEF
93 2012 Survey/reported WHO/UNICEF
82 2011 Survey/reported WHO/UNICEF
75 2010 Survey/reported WHO/UNICEF
86 2009 Survey/reported WHO/UNICEF
86 2008 Survey/reported WHO/UNICEF
82 2007 Survey/reported WHO/UNICEF
86 2006 Survey/reported WHO/UNICEF
85 2005 Survey/reported WHO/UNICEF
85 2004 Survey/reported WHO/UNICEF
89 2003 Survey/reported WHO/UNICEF
98 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
72 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2025
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.82 (0.67 - 1) 2019 Modelled IHME
0.81 (0.67 - 0.99) 2018 Modelled IHME
0.8 (0.65 - 0.98) 2017 Modelled IHME
0.79 (0.65 - 0.95) 2016 Modelled IHME
0.77 (0.63 - 0.94) 2015 Modelled IHME
0.77 (0.63 - 0.92) 2014 Modelled IHME
0.76 (0.62 - 0.92) 2013 Modelled IHME
0.76 (0.62 - 0.92) 2012 Modelled IHME
0.76 (0.62 - 0.92) 2011 Modelled IHME
0.76 (0.61 - 0.92) 2010 Modelled IHME
0.75 (0.61 - 0.92) 2009 Modelled IHME
0.75 (0.61 - 0.91) 2008 Modelled IHME
0.74 (0.61 - 0.91) 2007 Modelled IHME
0.74 (0.60 - 0.91) 2006 Modelled IHME
0.73 (0.60 - 0.91) 2005 Modelled IHME
0.73 (0.60 - 0.90) 2004 Modelled IHME
0.72 (0.59 - 0.89) 2003 Modelled IHME
0.71 (0.59 - 0.87) 2002 Modelled IHME
0.71 (0.58 - 0.87) 2001 Modelled IHME
0.7 (0.57 - 0.86) 2000 Modelled IHME
0.69 (0.57 - 0.85) 1999 Modelled IHME
0.69 (0.56 - 0.84) 1998 Modelled IHME
0.68 (0.56 - 0.83) 1997 Modelled IHME
0.67 (0.55 - 0.83) 1996 Modelled IHME
0.67 (0.55 - 0.83) 1995 Modelled IHME
0.67 (0.55 - 0.82) 1994 Modelled IHME
0.67 (0.54 - 0.82) 1993 Modelled IHME
0.67 (0.54 - 0.82) 1992 Modelled IHME
0.67 (0.54 - 0.82) 1991 Modelled IHME
0.67 (0.54 - 0.83) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
25.2 (13.10 - 37.30) 2014 Modelled Degenhardt L et al, 2017
13.8 (7.90 - 21.70) 2013 Survey/reported EMCDDA
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
2,471 (1,999 - 3,059) 1990 Modelled IHME
2,494 (2,024 - 3,077) 1991 Modelled IHME
2,520 (2,050 - 3,099) 1992 Modelled IHME
2,545 (2,073 - 3,119) 1993 Modelled IHME
2,572 (2,099 - 3,144) 1994 Modelled IHME
2,598 (2,114 - 3,202) 1995 Modelled IHME
2,632 (2,157 - 3,234) 1996 Modelled IHME
2,676 (2,199 - 3,274) 1997 Modelled IHME
2,725 (2,234 - 3,324) 1998 Modelled IHME
2,776 (2,265 - 3,394) 1999 Modelled IHME
2,822 (2,294 - 3,461) 2000 Modelled IHME
2,865 (2,344 - 3,501) 2001 Modelled IHME
2,908 (2,384 - 3,557) 2002 Modelled IHME
2,951 (2,419 - 3,633) 2003 Modelled IHME
2,993 (2,452 - 3,685) 2004 Modelled IHME
3,032 (2,473 - 3,744) 2005 Modelled IHME
3,068 (2,510 - 3,771) 2006 Modelled IHME
3,104 (2,538 - 3,799) 2007 Modelled IHME
3,138 (2,566 - 3,838) 2008 Modelled IHME
3,170 (2,589 - 3,866) 2009 Modelled IHME
3,202 (2,608 - 3,909) 2010 Modelled IHME
3,231 (2,643 - 3,928) 2011 Modelled IHME
3,256 (2,663 - 3,946) 2012 Modelled IHME
3,281 (2,685 - 3,969) 2013 Modelled IHME
3,310 (2,699 - 3,985) 2014 Modelled IHME
3,345 (2,712 - 4,075) 2015 Modelled IHME
3,418 (2,807 - 4,131) 2016 Modelled IHME
3,499 (2,852 - 4,283) 2017 Modelled IHME
3,551 (2,918 - 4,323) 2018 Modelled IHME
3,589 (2,932 - 4,398) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.48 (2.72 - 4.37) 2019 Modelled IHME
3.44 (2.71 - 4.29) 2018 Modelled IHME
3.4 (2.70 - 4.22) 2017 Modelled IHME
3.37 (2.67 - 4.19) 2016 Modelled IHME
3.32 (2.61 - 4.12) 2015 Modelled IHME
3.38 (2.66 - 4.17) 2014 Modelled IHME
3.35 (2.65 - 4.16) 2013 Modelled IHME
3.34 (2.63 - 4.12) 2012 Modelled IHME
3.3 (2.61 - 4.06) 2011 Modelled IHME
3.24 (2.59 - 3.99) 2010 Modelled IHME
3.21 (2.56 - 3.97) 2009 Modelled IHME
3.16 (2.54 - 3.91) 2008 Modelled IHME
3.09 (2.49 - 3.82) 2007 Modelled IHME
3.03 (2.43 - 3.76) 2006 Modelled IHME
3.01 (2.40 - 3.71) 2005 Modelled IHME
3.02 (2.41 - 3.74) 2004 Modelled IHME
3.02 (2.41 - 3.74) 2003 Modelled IHME
2.97 (2.38 - 3.66) 2002 Modelled IHME
2.9 (2.32 - 3.58) 2001 Modelled IHME
2.84 (2.27 - 3.50) 2000 Modelled IHME
2.81 (2.23 - 3.48) 1999 Modelled IHME
2.77 (2.18 - 3.45) 1998 Modelled IHME
2.77 (2.18 - 3.46) 1997 Modelled IHME
2.71 (2.13 - 3.39) 1996 Modelled IHME
2.63 (2.07 - 3.32) 1995 Modelled IHME
2.57 (2.02 - 3.22) 1994 Modelled IHME
2.52 (1.98 - 3.18) 1993 Modelled IHME
2.5 (1.97 - 3.13) 1992 Modelled IHME
2.48 (1.95 - 3.13) 1991 Modelled IHME
2.48 (1.94 - 3.13) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
15 (12 - 19) 2019 Modelled IHME
15 (12 - 19) 2018 Modelled IHME
15 (12 - 18) 2017 Modelled IHME
15 (12 - 18) 2016 Modelled IHME
14 (11 - 18) 2015 Modelled IHME
15 (11 - 18) 2014 Modelled IHME
14 (11 - 18) 2013 Modelled IHME
14 (11 - 18) 2012 Modelled IHME
14 (11 - 17) 2011 Modelled IHME
14 (11 - 17) 2010 Modelled IHME
14 (11 - 17) 2009 Modelled IHME
13 (11 - 16) 2008 Modelled IHME
13 (10 - 16) 2007 Modelled IHME
13 (10 - 16) 2006 Modelled IHME
12 (10 - 15) 2005 Modelled IHME
12 (10 - 15) 2004 Modelled IHME
12 (10 - 15) 2003 Modelled IHME
12 (10 - 15) 2002 Modelled IHME
12 (9 - 14) 2001 Modelled IHME
11 (9 - 14) 2000 Modelled IHME
11 (9 - 14) 1999 Modelled IHME
11 (9 - 14) 1998 Modelled IHME
11 (9 - 14) 1997 Modelled IHME
11 (8 - 13) 1996 Modelled IHME
10 (8 - 13) 1995 Modelled IHME
10 (8 - 12) 1994 Modelled IHME
10 (8 - 12) 1993 Modelled IHME
9 (7 - 12) 1992 Modelled IHME
9 (7 - 12) 1991 Modelled IHME
9 (7 - 12) 1990 Modelled IHME
17 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
40 (31 - 50) 2019 Modelled IHME
41 (31 - 50) 2018 Modelled IHME
41 (31 - 51) 2017 Modelled IHME
41 (31 - 51) 2016 Modelled IHME
41 (30 - 51) 2015 Modelled IHME
40 (30 - 51) 2014 Modelled IHME
40 (30 - 50) 2013 Modelled IHME
40 (30 - 50) 2012 Modelled IHME
40 (30 - 50) 2011 Modelled IHME
40 (30 - 50) 2010 Modelled IHME
40 (30 - 51) 2009 Modelled IHME
40 (30 - 50) 2008 Modelled IHME
40 (30 - 50) 2007 Modelled IHME
40 (30 - 50) 2006 Modelled IHME
40 (30 - 50) 2005 Modelled IHME
40 (30 - 51) 2004 Modelled IHME
41 (30 - 51) 2003 Modelled IHME
41 (30 - 51) 2002 Modelled IHME
41 (31 - 51) 2001 Modelled IHME
41 (31 - 51) 2000 Modelled IHME
41 (31 - 51) 1999 Modelled IHME
40 (30 - 51) 1998 Modelled IHME
40 (30 - 51) 1997 Modelled IHME
40 (30 - 51) 1996 Modelled IHME
41 (31 - 51) 1995 Modelled IHME
41 (31 - 51) 1994 Modelled IHME
41 (31 - 51) 1993 Modelled IHME
41 (31 - 51) 1992 Modelled IHME
41 (31 - 51) 1991 Modelled IHME
41 (31 - 51) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
72 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2025
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal
Year of goal
2025

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
5
2019
(4 - 7)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
15
2019
(12 - 19)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines